Find out how a professional services firm conducting market research on behalf of a pharmaceutical company used expert engagements to develop a go-to-market strategy.
The challenge
A leading professional services firm conducting market research on behalf of a global pharmaceutical company needed to better understand the key drivers and barriers to treatments of rare liver disease.
They needed to gain key industry insights to inform a go-to-market strategy they were developing for their client’s new therapy.
The solution
To support the customer with real-world expertise, we connected them with key opinion leaders (KOLs) and prescribers specializing in rare liver diseases.
Using our AI-driven expert matching, we custom-recruited specialists precisely aligned with the project’s requirements. This enabled qualitative interviews across five countries and a diverse range of expert profiles, including:
- Oncologists
- Gastroenterologists
- Hepatologists
- Surgeons
- Interventional radiologists
The outcome
We connected the customer with 77 KOLs and prescribers across the US, Germany, China, Japan, and France.
With these expert perspectives, the customer developed a market-ready strategy, equipping their pharma client with the confidence to launch their new rare liver disease therapy successfully.
Some of the high-quality experts we sourced for the customer included:
| Chief of Gastroenterology at a university school of medicine (Japan) |
Associate Professor of Radiology at a university hospital (USA) |
| Chief Hepatologist at a university hospital (China) |
Gastrointestinal surgeon at a private clinic (France) |
| Head of Visceral Oncology at a cancer center (Germany) |
|